{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:08:56Z","timestamp":1700438936137},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T00:00:00Z","timestamp":1181260800000},"content-version":"vor","delay-in-days":2259,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interven Cardiology"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p> <jats:italic>Glycoprotein (GP) IIb\/IIIa inhibitors were developed to block platelet aggregation and potentially to abolish thrombus formation. Clinical trials have demonstrated that GP IIb\/IIIa inhibitors are more potent antithrombotic agents than aspirin and heparin alone. GP IIb\/IIIa inhibitors reduce short\u2010 and long\u2010term complications of percutaneous revascularization. These agents also are effective as adjuncts to various treatment strategies for the management of patients with unstable angina (UA) or non\u2010Q\u2010wave myocardial infarction (NQMI). Furthermore, recent clinical trials with a small number of patients suggest that GP IIb\/IIIa inhibitors in combination with low\u2010dose fibrinolytics are safe and effective for the treatment of ST segment elevation myocardial infarction. The clinical trials of GP IIb\/IIIa inhibitors summarized here examined different patient populations managed under different strategies. Moreover, these agents have different indications for clinical use and varying safety profiles<\/jats:italic>. (J Interven Cardiol 2001;14:129\u2013142)<\/jats:p>","DOI":"10.1111\/j.1540-8183.2001.tb00724.x","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T03:43:12Z","timestamp":1181360592000},"page":"129-142","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Trials of Glycoprotein IIb\/IIIa Inhibitors"],"prefix":"10.1111","volume":"14","author":[{"given":"J.","family":"DAVIDTALLEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.1998.tb00145.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.1999.tb00208.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.1999.tb00220.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2000.tb00299.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301402"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long\u2010term protection from myocardial ischemic events in a randomized trial of brief integrin \u03b23 blockade with percutaneous coronary intervention","volume":"278","author":"Topol EJ","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.12.2882"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362401"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.15.1951"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80345-2"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1757"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448040-00007"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v138.99236"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54041-2"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1488"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00575-4"},{"key":"e_1_2_1_19_2","first-page":"72A","article-title":"Eptifibatide during immediate percutaneous coronary intervention (PCI) in the acute coronary\u2010 syndromes (ACS): Findings from the PURSUIT study. (abstract)","volume":"33","author":"Lorenz TJ","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1445"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomized placebo\u2010controlled and balloon angioplasty\u2010controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade","volume":"352","author":"The EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"e_1_2_1_22_2","first-page":"I","article-title":"The EPISTENT trial at 6 months: Relative and combined effects of ahciximab and stenting on reduction of acute ischemic events and late revascularization (abstract)","volume":"98","author":"Lincoff AM","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00091-H"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1528"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540300029029"},{"key":"e_1_2_1_26_2","first-page":"I","article-title":"Six\u2010month angiographic outcome with abciximab and stents: The EPISTENT angiographic substudy (abstract)","volume":"98","author":"Lincoff AM","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382103"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390704"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351801"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00200-8"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609123351103"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370702"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.24.2386"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.21.2720"},{"key":"e_1_2_1_37_2","first-page":"I","article-title":"Enhanced early reperfusion at 60 minutes with low\u2010dose reteplase combined with full\u2010dose abciximab in acute myocardial infarction: Preliminary results from the GUSTO\u20104 pilot (SPEED) dose\u2010ranging trial","volume":"98","author":"Ohman EM","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.4.846"},{"key":"e_1_2_1_39_2","first-page":"I","article-title":"INTRO AMI: Marked enhancement of arterial patency with eptifibatide and low\u2010dose tPA in acute myocardial infarction","volume":"100","author":"Brener SJ","year":"1999","journal-title":"Circulation"}],"container-title":["Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8183.2001.tb00724.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8183.2001.tb00724.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T11:58:25Z","timestamp":1700395105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8183.2001.tb00724.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1111\/j.1540-8183.2001.tb00724.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8183.2001.tb00724.x","archive":["Portico"],"relation":{},"ISSN":["0896-4327","1540-8183"],"issn-type":[{"value":"0896-4327","type":"print"},{"value":"1540-8183","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}